Form D · Pharmaceuticals

Lyric Pharmaceuticals Inc.

South San Francisco, CA · CIK 0001634389

Offering snapshot reported Apr 24, 2017 · SEC filing

Reported sold: $26.8M
Investors reported: 13
Minimum accepted: $0
First sale: Feb 11, 2015

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$7,814,562 → $26,785,593
Reported investors12 → 13

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Apr 24, 2017	Amendment	$26,785,593	$18,971,031vs Feb 26, 2015	13	SEC filing
Feb 26, 2015	Initial	$7,814,562	No comparison	12	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-234847

$885,625.25 of the total amount sold is comprised of the conversion of principal and accrued interest in connection with outstanding convertible promissory notes.

Source: Form D, filed Apr 24, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Casey Cunningham	Director
M. Scott Harris	Executive
Jason Hong	Director
Kevin Lalande	Director
Niall O'donnell	Director
David Wurtman	Director, Executive
Sanford Zweifach	Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

601 Gateway Blvd., Suite 1020
South San Francisco, CA, 94080